Article Search
닫기

Journal of Cancer Prevention

Review

J Cancer Prev 2023; 28(4): 143-149

Published online December 30, 2023

https://doi.org/10.15430/JCP.2023.28.4.143

© Korean Society of Cancer Prevention

Cyclic GMP-AMP Synthase in Cancer Prevention

Weidong Chen1,2 , Ga-Eun Lee1,2 , Dohyun Jeung1,2 , Jiin Byun1,2 , Wu Juan1,2 , Yong-Yeon Cho1,2

1BK21-Four, College of Pharmacy, The Catholic University of Korea, 2RCD Control Material Research Institute, The Catholic University of Korea, Bucheon, Korea

Correspondence to :
Yong-Yeon Cho, E-mail: yongyeon@catholic.ac.kr, https://orcid.org/0000-0003-1107-2651

Received: December 20, 2023; Accepted: December 26, 2023

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Cyclic GMP-AMP (cGAMP), synthesized by cGAMP synthase (cGAS), serves as a secondary messenger that modulates various cellular processes, including cell proliferation, cell death, immune response, and inflammation. cGAS is activated upon detecting cytoplasmic DNA, which may originate from damaged genomic and mitochondrial DNA or from viral and bacterial infections. The presence of DNA in the cytoplasm can trigger a substantial inflammatory reaction and cytokine production via the cGAS-STING signaling pathway. Consequently, specific inhibitors targeting this pathway hold significant potential as chemopreventive agents. In this review, we explore the potential effectiveness of modulating cGAS activity. We discuss the role of cGAMP, the mechanism of action for distinguishing between self and foreign DNA, and the possible functions of cGAS within the nucleus.

Keywords: Cell proliferation, Cell death, Immune response, Inflammation, Chemoprevention

Share this article on :

Related articles in JCP

Most KeyWord